CD274 and hyperthyroidism: The frequency of hyperthyroidism changes along with the type of treatment: patients treated with anti-PD-1 have an increased frequency of hyperthyroidism compared with those treated with anti-CLTL-4 and anti-PD-L1, 3.2% vs. 1.7% and 0.6%, respectively [65].